Results 101 to 110 of about 237,126 (244)

Optimal Disease Eradication [PDF]

open access: yes
Using a dynamic model of the control of an infectious disease, we derive the conditions under which eradication will be optimal. When eradication is feasible, the optimal program requires either a low vaccination rate or eradication.
Barrett, Scott, Hoel, Michael
core   +3 more sources

A risk science perspective on vaccines

open access: yesRisk Analysis, Volume 44, Issue 12, Page 2780-2796, December 2024.
Abstract Vaccines can be seen as one of the greatest successes in modern medicine. Good examples are the vaccines against smallpox, polio, and measles. Unfortunately, vaccines can have side effects, but the risks are considered by the health authorities and experts to be small compared to their benefits.
Ingrid Glette‐Iversen   +2 more
wiley   +1 more source

Polio Eradication: How the War on Terror Has Led to the Persistence of Polio in Afghanistan, Pakistan, and Nigeria [PDF]

open access: yes, 2013
In 1988, the World Health Organization (WHO) initiated a campaign to eradicate the polio virus from the world population (Bari 2006). Since 1988, the WHO has used polio vaccines to successfully interrupt transmission of the disease to new individuals in ...
Rouhana, John Michel
core   +1 more source

Role of Serial Polio Seroprevalence Studies in Guiding Implementation of the Polio Eradication Initiative in Kano, Nigeria: 2011-2014. [PDF]

open access: yes, 2016
BACKGROUND: Nigeria was one of 3 polio-endemic countries before it was de-listed in September 2015 by the World Health Organization, following interruption of transmission of the poliovirus. During 2011-2014, Nigeria conducted serial polio seroprevalence
Abdullahi Walla   +19 more
core   +1 more source

Poliomyelitis Surveillance: The Compass for Eradication [PDF]

open access: yesJournal of Infectious Diseases, 1997
Effective disease surveillance is a key strategy of the global polio eradication initiative. In an effort to strengthen the quality of polio surveillance as a prerequisite to achieving and certifying eradication, surveillance assessments were conducted in 28 countries in the World Health Organization African, Eastern Mediterranean, and European Regions
M E, Birmingham   +3 more
openaire   +2 more sources

“Spanish flu,” encephalitis lethargica, and COVID‐19: Progress made, lessons learned, and directions for future research

open access: yesEuropean Journal of Neurology, Volume 31, Issue 11, November 2024.
Abstract One hundred years ago, an influenza pandemic swept across the globe that coincided with the development of a neurological condition, named "encephalitis lethargica" for the occurrence of its main symptom, the sudden onset of sleepiness that either developed into coma or gradually receded.
Michael Brainin   +2 more
wiley   +1 more source

Comparative study of antibody levels developed by vaccination against polio virus in population after vaccine type alteration [PDF]

open access: yes, 2015
During clinical trials, samples from Hungarian patients of different age groups were tested for antibodies against all 3 serotypes of poliovirus, a member of Picornaviridae family.
Farkas, Ágnes   +3 more
core   +1 more source

Protective role of antibodies in enteric virus infections: Lessons from primary and secondary immune deficiencies

open access: yesImmunological Reviews, Volume 328, Issue 1, Page 243-264, November 2024.
Summary Enteric viruses are the main cause of acute gastroenteritis worldwide with a significant morbidity and mortality, especially among children and aged adults. Some enteric viruses also cause disseminated infections and severe neurological manifestations such as poliomyelitis.
Quentin Riller   +4 more
wiley   +1 more source

A statistical model of the international spread of wild poliovirus in Africa used to predict and prevent outbreaks. [PDF]

open access: yesPLoS Medicine, 2011
Outbreaks of poliomyelitis in African countries that were previously free of wild-type poliovirus cost the Global Polio Eradication Initiative US$850 million during 2003-2009, and have limited the ability of the program to focus on endemic countries.
Kathleen M O'Reilly   +8 more
doaj   +1 more source

Immunoglobulin A Antibodies: From Protection to Harmful Roles

open access: yesImmunological Reviews, Volume 328, Issue 1, Page 171-191, November 2024.
ABSTRACT Immunoglobulin A (IgA) is the most abundantly produced antibody in humans. IgA is a unique class of immunoglobulin due to its multiple molecular forms, and a defining difference between the two subclasses: IgA1 has a long hinge‐region that is heavily O‐glycosylated, whereas the IgA2 hinge‐region is shorter but resistant to bacterial proteases ...
Patrick J. Gleeson   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy